大催乳素瘤与无功能垂体腺瘤及妊娠结局
英国全国前瞻性观察性人群病例系列研究,3年内通过英国产科监测系统纳入71例妊娠合并垂体瘤患者,与两个对照组比较。多数大催乳素瘤和无功能腺瘤患者妊娠结局良好;无功能腺瘤在妊娠中比既往认为的更常见,并可在妊娠期新发表现为垂体扩张症状。
要点
- 妊娠合并垂体瘤患者中,孕前接受手术或放疗的9例均无症状性肿瘤扩张。
- 无功能腺瘤患者剖宫产率高于对照组(相对风险2.06,置信区间1.26-3.36,P=.035)。
- 无功能腺瘤可在妊娠期新发表现为垂体扩张症状,需关注。
核心结论
- 多数大催乳素瘤和无功能腺瘤患者妊娠结局良好。
- 无功能垂体腺瘤在妊娠中比既往认为的更常见,并可在妊娠期新发表现为垂体扩张症状。
研究设计与样本
- 英国全国前瞻性观察性人群病例系列研究,在英国所有顾问领导的产科单位进行,为期3年,使用英国产科监测系统。
- 纳入孕前或孕期诊断的大催乳素瘤(10 mm或以上)或无功能垂体腺瘤女性,与两个对照组比较:英国产科监测系统单胎(n=2,205)或双胎(n=27)妊娠队列,以及国家统计局数据(n=2,703,102)。
主要发现
- 共71例确诊妊娠合并垂体瘤(49例大催乳素瘤、16例无功能腺瘤、3例肢端肥大症、3例库欣病)。
- 垂体瘤女性比对照组女性年长4岁(P<.001)。
- 孕前接受手术或放疗的9例女性均未发生症状性肿瘤扩张;孕前诊断的大催乳素瘤40例中6例、无功能腺瘤7例中1例发生症状性肿瘤扩张;孕期诊断的无功能腺瘤5例中3例发生。
- 2例发生垂体卒中,均伴有肿瘤或周围垂体组织扩张症状。
- 在可能的准确度范围内,无证据表明垂体瘤与不良妊娠结局(妊娠期高血压、子痫前期、早产、死产)相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the monitoring, management, and outcomes of pituitary tumors in pregnancy. METHODS: A national, prospective, observational, population-based case series study was conducted in all U.K. consultant-led obstetric units over 3 years using the U.K. Obstetric Surveillance System. To evaluate rates of adverse pregnancy outcomes, women with a macroprolactinoma (10 mm or greater) or nonfunctioning pituitary adenoma, diagnosed before or during pregnancy, were compared with two comparison groups: 1) a U.K. Obstetric Surveillance System cohort with singleton (n=2,205) or twin (n=27) pregnancy; and 2) data from the Office of National Statistics (n=2,703,102). Main outcome measures were the incidence, management, and frequency of adverse maternal and offspring outcomes of pituitary tumors in pregnancy. RESULTS: There were 71 confirmed cases of pituitary tumors in pregnancy (49 macrolactinoma, 16 nonfunctioning adenomas, three acromegaly, three Cushing's disease). The women with pituitary tumors were 4 years older than comparison women (P<.001). None of the nine women treated with surgery or radiotherapy before pregnancy had symptomatic tumor expansion. This occurred in 6 of 40 women with macroprolactinomas and one of seven nonfunctioning adenomas diagnosed before conception and in three of five women with nonfunctioning adenomas diagnosed in pregnancy. Two women had pituitary apoplexy, both of whom also had symptoms of expansion of tumor or surrounding pituitary tissue. To within the level of accuracy possible, there was no evidence that pituitary tumors were associated with adverse pregnancy outcomes (pregnancy-induced hypertension, preeclampsia, preterm labor, stillbirth). Women with nonfunctioning adenomas were more likely to have cesarean delivery compared with women in a control group (relative risk 2.06, confidence interval 1.26-3.36, P=.035). CONCLUSION: The majority of women with macroprolactinomas and nonfunctioning adenomas have good pregnancy outcomes. Nonfunctioning pituitary adenomas occur more commonly in pregnancy than previously thought and can present de novo with symptoms of pituitary expansion in pregnancy.
引用
- Lambert K, Rees K, Seed PT, et al. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes. Obstet Gynecol. 2017. PMID: 27926659. doi:10.1097/AOG.0000000000001747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。